Bionano Genomics, Inc.
(NASDAQ: BNGO)

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

3.836

-0.014 (-0.36%)
Range 3.800 - 3.947   (3.87%)
Open 3.870
Previous Close 3.850
Bid Price 0.712
Bid Volume 18
Ask Price 0.720
Ask Volume 13
Volume 22,137
Value -
Remark
Delayed prices. Updated at 10 May 2025 04:00.
Data powered by
View All Events


Share your investing ideas
Please login to view stock data and analysis